Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Li Xu1, Min Li1, Wu He1

  • 1Center for Drug Evaluation National Medical Products Administration Beijing China.

Medcomm
|July 8, 2024
PubMed
Summary
This summary is machine-generated.

The SARS-CoV-2 virus continues to evolve, with new variants like JN.1 causing increased hospitalizations. This review examines COVID-19 vaccines and proposes strategies for timely development and monitoring of future pandemic threats.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A cytosolic class I small heat shock protein, RcHSP17.8, of Rosa chinensis confers resistance to a variety of stresses to Escherichia coli, yeast and Arabidopsis thaliana.

Plant, cell & environment·2009
Same author

Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture.

Neurochemistry international·2009
Same author

[Clinical features of interstitial pneumonitis due to interferon alpha therapy for chronic hepatitis C].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University·2009
Same author

Anti-hypoxic activity of the ethanol extract from Portulaca oleracea in mice.

Journal of ethnopharmacology·2009
Same author

[Effects of artemether and dihydroarteannuin on mouse model of scleroderma].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2009
Same author

Astragaloside IV attenuates cerebral ischemia-reperfusion-induced increase in permeability of the blood-brain barrier in rats.

European journal of pharmacology·2009

Area of Science:

  • Virology
  • Immunology
  • Public Health

Context:

  • The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to evolve, with recent variants like JN.1 rapidly emerging and causing increased hospitalizations globally.
  • Despite the availability of XBB sub-lineage vaccines in 2024, the continuous evolution of SARS-CoV-2 necessitates ongoing vaccine updates and guaranteed regular availability of coronavirus disease 2019 (COVID-19) vaccines.

Purpose:

  • To review the current landscape of COVID-19 vaccines.
  • To explore strategies for accelerating vaccine development and approval.
  • To propose enhancements for variant monitoring and strain recommendation mechanisms.

Summary:

  • This review analyzes the current status of COVID-19 vaccines in light of evolving SARS-CoV-2 strains.

Related Experiment Videos

  • It discusses strategies to expedite vaccine development and regulatory approval processes.
  • Proposals include improved variant surveillance and a robust strain recommendation system for rapid vaccine updates.

    • Impact:

    • Provides insights into optimizing vaccine development and regulatory pathways for both current and future pandemics.
    • Offers recommendations for enhancing global preparedness against emerging viral threats.
    • Aims to ensure timely access to effective vaccines against rapidly evolving pathogens.